PHASE I SBIR CONTRACT - TOPIC 415 - A Compact and Retrofittable Electronic Brachytherapy Source for Cancer Radiotherapy
PHASE I SBIR CONTRACT - TOPIC 415 - A Compact and Retrofittable Electronic Brachytherapy Source for Cancer Radiotherapy
批准号:
10496695
负责人:
CHUNGUANG JING
金额:
$39.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-16 至 2022-06-15
关键词:
BrachytherapyCaliberCharacteristicsClinicalCommunitiesContractsDevelopmentDevicesDimensionsDoseDose-RateElectron BeamElectronsElementsFutureGoalsHigh-Dose Rate BrachytherapyHospitalsIn VitroLaboratoriesMeasurementMeasuresMedicalPatientsPenetrationPhasePhotonsRadiationRadioisotopesReadinessRoboticsRoentgen RaysSmall Business Innovation Research GrantSourceStructureSystemTechnologyTestingThickTissuesWeightarmattenuationbasecancer radiation therapyclinically relevantconditioningdesignefficacy studyimprovedin silicointerestlight weightnovelprototypeuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The use of electronic brachytherapy (EB) has grown rapidly over the past decade, and is gaining significant
interest from the global medical community as an improved user-friendly technology. However, the present EB machines
all use electron beams at energies of 100 kV or less to generate the X-ray photons, which limits their use to low dose-rate
brachytherapy. In this proposal, Euclid Beamlabs focuses on the development of an ultra-compact and light weight 1-
MeV electron source to generate and deliver >250 kV X-ray photons to the patient. The device is intended to retrofit to
existing brachytherapy applicators. Our proposed accelerating structure is a dielectric-based accelerator. Because of the
use of high permittivity dielectrics, the transverse size of the cavity is significantly reduced, becoming comparable to the
thickness of a pencil. With the help of optimized focusing elements, the beam will be transported through a 1~2-mm
diameter pipe to the Bremsstrahlung radiation target, thus delivering the dose in a highly localized regime. The
dimension of the pipe will be chosen for compatibility with existing brachytherapy applicators. In Phase I, we will develop
a fully functioning prototype and measure its critical parameters, including the delivered electron and photon energies,
the dose rate, etc. The Technical Readiness Level (TRL) of the developed technology will reach TRL4 (feasibility proved)
upon the completion of Phase I.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金